Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 – Clinical Trial Not Allowed)

Posted Date: September 07, 2017

Earliest Submission Date: October 28, 2017

Application Due Date: November 27, 2017; June 27, 2018; October 24, 2018; June 27, 2019; October 24, 2019; June 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


The purpose of this funding opportunity announcement is to support basic research examining how Electronic Nicotine Delivery Systems (ENDS) aerosols affect normal and disease states relevant to human cells, tissues and organs.


Leave a Reply